High risk regarding the calculation definition. The GSE capital structure is unique, involving government-held Senior Preferred stock and warrants for 79.9% of common equity. The trap lies in the definition of 'Shares Outstanding': if the government has not fully exercised warrants or converted stakes by Day 1, the 'Shares Outstanding' listed on the exchange could be far lower than the 'Fully Diluted' count. This means even if the company's valuation is $500B, the calculated 'Market Cap' (Listed Shares x Price) could be artificially low (e.g., <$150B), creating a discrepancy between economic value and the resolution figure. Additionally, the distinction between a formal 'IPO' and a mere 'Uplisting' is ambiguous for GSEs.

This event directly dictates the fate of Freddie Mac (FMCC) and Fannie Mae (FNMA) shares. A successful IPO with a high market cap implies a 'Recap & Release' scenario, potentially sending shares multi-bagging. Conversely, 'No IPO' or a harsh dilution plan could crush the stock. Additionally, the liquidity and capital structure of GSEs impact MBS spreads, causing moderate ripple effects on the US 10Y Yield and the Financial sector (XLF) which holds significant GSE debt.

April 28, 2026 - April 30, 2026, the 'No IPO by June 30, 2026' option plunged from 93.2c to 53.15c before rebounding to 68.3c, while the '150–200B' and '200–250B' options surged to 45.2c and 47.7c respectively on April 29 before dropping back. This was caused by severe market irrationality or potential manipulation driven by unverified rumors in a low-liquidity environment, leading to a temporary breakdown of probabilities before partially correcting. April 17, 2026 - April 23, 2026, prices for all options remained relatively flat, with no single option showing a drastic movement of over 10 cents, reaffirming the extremely solid market consensus that an IPO by the deadline is impossible. April 6, 2026 - April 16, 2026, prices for all options remained relatively flat, with fluctuations well under 5 cents, reaffirming the extremely solid market consensus that an IPO by the deadline is impossible. March 20, 2026 - March 26, 2026, prices for all options remained extremely flat with fluctuations under 2 cents, as the market consensus solidified that an IPO by the deadline is impossible. March 13, 2026 - March 19, 2026, prices for all options remained highly stable, with no fluctuations exceeding 2 cents. The market has fully priced in the expectation of an 'IPO delay,' with the 'No IPO' option consolidating in the 94-95c range. March 9, 2026 - March 12, 2026, the '<150B' option rose slightly from 0.5c to 2.35c, attributed to speculative buying in a low-liquidity environment betting on a fringe 'rushed/distressed listing' scenario, but this did not establish a broader trend.

The prediction market currently implies an approximately 31.7% chance of a Freddie Mac IPO occurring by June 30, 2026 (as the 'No IPO' option is trading at only 68.3c). This violently diverges from the consensus of mainstream financial experts (such as Michael Burry) and lawmakers (like French Hill), who maintain that an IPO is entirely off the table for 2026 due to undercapitalization and lack of any regulatory filings (S-1). The market's mispricing is likely driven by speculative hype in a low-liquidity environment.